VEGFA and diabetic macular edema: It is the smallest of the anti-VEGF antibodies, with a molecular weight of 26 kDa, compared with 115 kDa for aflibercept and 48 kDa for ranibizumab, which have proven useful in the management of diabetic macular edema (DME).